Drug
Wif 2402
Wif 2402: highest development phase Phase 1, developed by Whanin Pharmaceutical Company. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Whanin Pharmaceutical Company
Trials
| Drug | Phase | Indication |
|---|---|---|
| WIF-2402 NCT07930312 | Phase 1 |
Latest
No recent events.
Follow Wif 2402 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.